Tyler-Stone Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$587K Sell
5,294
-200
-4% -$21.3K 0.09% 184
2025
Q1
$616K Sell
5,494
-609
-10% -$62.8K 0.11% 168
2024
Q4
$564K Hold
6,103
0.1% 175
2024
Q3
$512K Buy
6,103
+3,267
+115% +$249K 0.1% 184
2024
Q2
$195K Sell
2,836
-14
-0.5% -$934 0.08% 193
2024
Q1
$209K Sell
2,850
-50
-2% -$3.85K 0.09% 188
2023
Q4
$235K Hold
2,900
0.12% 164
2023
Q3
$217K Hold
2,900
0.12% 147
2023
Q2
$224K Buy
+2,900
New +$231K 0.13% 144
2022
Q4
$254K Sell
2,958
-300
-9% -$23.8K 0.17% 123
2022
Q3
$201K Hold
3,258
0.15% 130
2022
Q2
$201K Sell
3,258
-100
-3% -$6.19K 0.13% 147
2022
Q1
$200K Sell
3,358
-500
-13% -$32K 0.11% 169
2021
Q4
$280K Buy
+3,858
New +$266K 0.15% 143

Other funds holding GILD

Tyler-Stone Wealth Management's GILD Position: Q2 2025 in Review

Tyler-Stone Wealth Management reduced its Gilead Sciences (GILD) stake by 3.6% in Q2 2025, selling an estimated $21.3K and leaving 5,294 shares worth $587K. The position accounts for 0.09% of the portfolio, ranked #184.

Tyler-Stone Wealth Management first reported a position in GILD in Q4 2021 and has held it in 14 quarters since. The position peaked at $616K in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Tyler-Stone Wealth Management held 5,294 shares of Gilead Sciences worth $587K as of Q2 2025.
  • Tyler-Stone Wealth Management sold 200 Gilead Sciences shares in Q2 2025, an estimated $21.3K.
  • Gilead Sciences made up 0.09% of Tyler-Stone Wealth Management's portfolio in Q2 2025, its #184 holding.
  • Tyler-Stone Wealth Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 14 quarters since.
  • Tyler-Stone Wealth Management's Gilead Sciences position peaked at $616K in Q1 2025.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Tyler-Stone Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.